The MAHA announcements around autism, Tylenol (acetaminophen), and leucovorin have ignited intense debate—alongside real confusion for clinicians and families. We’re hosting an urgent, no-fluff briefing to clarify what was actually announced, what the evidence shows (and doesn’t), and how to communicate responsibly with patients. Recent federal communications included moves toward acetaminophen label changes in pregnancy and expanded attention to leucovorin in specific autism subgroups—sparking strong responses across the medical community. Autism Science Foundation+3U.S. Food and Drug Administration+3STAT+3

Join us for an exclusive Functional Medicine Conference designed for medical professionals eager to enhance their clinical skills and for practice decision-makers seeking cutting-edge business strategies to grow their practices.

🚨 Stay ahead of the latest regulatory changes impacting GLP-1 prescribers using compounded medications. Watch our latest APN Podcast episode this Thursday for expert insights on compliance, best practices, and what these updates mean for your practice.

🚨 Stay ahead of the latest regulatory changes impacting GLP-1 prescribers using compounded medications. Watch our latest APN Podcast episode this Thursday for expert insights on compliance, best practices, and what these updates mean for your practice.

🚨 Stay ahead of the latest regulatory changes impacting GLP-1 prescribers using compounded medications. Watch our latest APN Podcast episode this Thursday for expert insights on compliance, best practices, and what these updates mean for your practice.

Refine Your Technique | Optimize Patient Outcomes | Elevate Your Aesthetic Practice 
Are you ready to refine your technique, optimize patient outcomes, and integrate cutting-edge strategies into your practice? 

This exclusive one-day course is designed for beginning, intermediate and experienced injectors who want to take their skills to the next level.